Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is one of the most widely spread diseases, affecting around 90% of the patients with diabetes. Metabolomics has proven useful in diabetes research discovering new biomarkers to assist in therapeutical studies and elucidating pathways of interest. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mora-Ortiz, Marina, Alcala-Diaz, Juan F., Rangel-Zuñiga, Oriol Alberto, Arenas-de Larriva, Antonio Pablo, Abollo-Jimenez, Fernando, Luque-Cordoba, Diego, Priego-Capote, Feliciano, Malagon, Maria M., Delgado-Lista, Javier, Ordovas, Jose M., Perez-Martinez, Pablo, Camargo, Antonio, Lopez-Miranda, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609192/
https://www.ncbi.nlm.nih.gov/pubmed/36289459
http://dx.doi.org/10.1186/s12916-022-02566-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609192/
https://www.ncbi.nlm.nih.gov/pubmed/36289459
http://dx.doi.org/10.1186/s12916-022-02566-z

Ejemplares similares